Advancing a program commits:
- Years of scientist time
- Preclinical infrastructure
- Chemistry and modality investment
- Translational development resources
- Portfolio opportunity cost
Program Evaluation Infrastructure
Plex is how modern drug teams decide which programs to advance.
We built the structured system that unifies biological & chemical evidence, internal data, therapeutic feasibility, and risk into one repeatable evaluation — before capital is committed.
Before a program moves forward, it gets Plexed.
4–6 wksSaved per evaluation cycle
7Integrated evaluation dimensions
Oncology, CNS, Inflammatory Disease & moreActive across therapeutic areas
33x more accurate than LLMs alone
Peer-reviewed research published on bioRxiv
Grounded in scientific data
Plex augments LLMs with curated biomedical knowledge graphs, delivering accurate, data-backed answers instead of hallucinations.
The Core Problem
Program progression is not a research problem.
It’s a capital allocation decision.
Yet in most organizations:
- Evidence weighting varies by team
- Internal data is fragmented
- Risk is surfaced late
- Nomination decks are rebuilt for every committee
- Comparability across programs is weak
Weak structure early becomes expensive downstream.
Evaluation Framework
A program is evaluated structurally — not narratively.
When a program is Plexed, it is evaluated across seven integrated dimensions. Not a literature summary — a repeatable decision framework.
Mechanistic Strength
Causal biology and pathway confidence
Human Genetics
Genetic association weighting and evidence quality
Druggability
Chemistry feasibility and modality assessment
Safety & Off-Target
Off-target risk and safety hypotheses
Internal Data
Concordance of proprietary experimental data
Translational Readiness
Biomarker availability and clinical translatability
Confidence Mapping
Explicit scoring of confidence and known unknowns
Impact
Structure reduces rework.
Clarity reduces waste.
Short-Term
- 4–6 weeks saved per target synthesis cycle
- Up to 70% reduction in cross-functional rework
- 3x faster committee alignment on go/no-go decisions
Medium-Term
- Feasibility constraints surfaced months earlier in the pipeline
- Fewer late-stage surprises — risk hypotheses documented upfront
- Capital redeployed from low-confidence to high-confidence programs
Long-Term
- Higher probability of advancing targets capable of producing best-in-class medicines
- Institutional evaluation memory that compounds across every program
Measure
Twice,
Cut Once.
Validation
Used in real programs.
Plex supports strategic expansion and rigorous internal validation.
Identified a new therapeutic opportunity and strengthened IP position
“Plex’s platform helped identify a promising new therapeutic opportunity for a CNS drug development program I led… significantly strengthened our IP position… instrumental to expanding the program’s potential value.”
Findings independently confirmed by internal analysis
“…provided unparalleled efficiency and clear direction… many findings were confirmed by our internal independent analysis… a great help to our development program.”
Why Plex
Research tools help you explore.
Plex helps you decide.
Capability
Literature AI
Internal Slide Decks
Plex
Biology + chemistry integrated
✓
~
✓
Internal + public evidence unified
✓
~
✓
Risk surfaced early
—
—
✓
Comparable across programs
—
—
✓
Internal data integration
—
~
✓
Built for governance decisions
—
—
✓
Built For
Designed for decision owners.
Plex is not a research assistant. It is evaluation infrastructure — built for decision-makers and the scientists who inform them.
VP / Head of Discovery Biology
Responsible for nomination quality and scientific rigor.
See how Biology leads use Plex →Head / VP of Translational Science
Ensures biomarker clarity and risk readiness.
See how Translational teams use Plex →CSO / Portfolio Committee
Allocates capital across multiple programs.
See how CSOs use Plex →Growth Path
From single program to system of record.
Other platforms help you explore. Plex helps you decide.
Start with
- Individual program evaluation
Expand to
- Cross-program comparability
- Institutional memory
- Portfolio prioritization
- Governance consistency
Frequently Asked Questions
Common questions about Plex.
What is Plex Research?
Plex is evaluation infrastructure for drug discovery. It provides a structured, repeatable framework for evaluating biological targets before capital is committed — unifying mechanistic biology, human genetics, chemistry feasibility, safety, internal data, and translational readiness into one comparable assessment.
Who uses Plex?
Plex is designed for decision owners in drug discovery: VPs and Heads of Discovery Biology responsible for nomination quality, Heads of Translational Science ensuring biomarker and risk readiness, and CSOs and Portfolio Committees allocating capital across programs.
How is Plex different from literature AI or research tools?
Research tools help you explore — they surface papers and summarize content. Plex helps you decide — it integrates biology and chemistry, unifies internal and public evidence, surfaces risk early, and enables comparable evaluations across programs, built specifically for governance decisions.
How long does a Plex evaluation take?
A typical target evaluation is delivered within weeks, not months. The structured framework eliminates the repetitive synthesis cycles that normally consume 4–6 weeks per target, giving teams a decision-ready assessment significantly faster than conventional approaches.
Does Plex integrate with internal proprietary data?
Yes. Plex unifies internal experimental data with public biological and chemical evidence into a single evaluation. Proprietary data concordance is one of the seven core evaluation dimensions, ensuring your internal findings are weighted alongside external evidence under strict confidentiality.
What therapeutic areas does Plex cover?
Plex has been used across oncology, CNS, immunology, and rare disease programs. The evaluation framework is indication-agnostic — it assesses target biology, druggability, safety, and translational readiness regardless of therapeutic area.
Get Started
See how Plex would evaluate your next program.
Confidential. Structured. Executive-ready.
Delivered in weeks, not quarters — no multi-month integration required.